CIK 0001737287
- Non-accelerated filer
- Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823562771
- Phone
- +1 650-457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Humer Franz B Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | Humer Franz B Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2024-12-05 | Humer Franz B Director | Sale | −9,221 | $2.16 | $20K | 307,507 |
| 2024-06-05 | Humer Franz B Director | Grant or award | +61,475 | 316,728 | ||
| 2024-06-05 | Humer Franz B Director | Grant or award · Stock Option (Right to buy) | +95,541 | 95,541 | ||
| 2024-05-30 | Humer Franz B Director | Sale | −11,200 | $2.34 | $26K | 255,253 |
| 2023-06-13 | Humer Franz B Director | Grant or award | +74,561 | 266,453 | ||
| 2022-06-15 | Humer Franz B Director | Grant or award | +44,178 | 191,892 | ||
| 2021-06-10 | Humer Franz B Director | Grant or award | +16,498 | 147,714 | ||
| 2020-06-05 | Humer Franz B Director | Grant or award | +9,969 | 131,216 | ||
| 2019-06-06 | Humer Franz B Director | Grant or award | +16,377 | 121,247 | ||
| 2018-10-15 | Humer Franz B Director | Purchase | +30,000 | $18.00 | $540K | 30,000 |
| 2018-10-15 | Humer Franz B Director | Conversion | +74,870 | 104,870 | ||
| 2018-10-15 | Humer Franz B Director | Conversion · Series A Convertible Preferred Stock | −14,261 | 0 |
Page 1 of 1 · 14 trades